• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟康唑耐药的耳念珠菌易被唾液组蛋白 5 杀伤,且易被固有宿主防御机制杀灭。

Fluconazole-Resistant Candida auris Is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses.

机构信息

Department of Oral Biology, School of Dental Medicine, University at Buffalo, Buffalo, New York, USA.

Department of Oral Biology, School of Dental Medicine, University at Buffalo, Buffalo, New York, USA

出版信息

Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01872-17. Print 2018 Feb.

DOI:10.1128/AAC.01872-17
PMID:29158282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5786754/
Abstract

is a newly identified species causing invasive candidemia and candidiasis. It has broad multidrug resistance (MDR) not observed for other pathogenic species. Histatin 5 (Hst 5) is a well-studied salivary cationic peptide with significant antifungal activity against and is an attractive candidate for treating MDR fungi, since antimicrobial peptides induce minimal drug resistance. We investigated the susceptibility of to Hst 5 and neutrophils, two first-line innate defenses in the human host. The majority of clinical isolates, including fluconazole-resistant strains, were highly sensitive to Hst 5: 55 to 90% of cells were killed by use of 7.5 μM Hst 5. Hst 5 was translocated to the cytosol and vacuole in cells; such translocation is required for the killing of by Hst 5. The inverse relationship between fluconazole resistance and Hst 5 killing suggests different cellular targets for Hst 5 than for fluconazole. showed higher tolerance to oxidative stress than , and higher survival within neutrophils, which correlated with resistance to oxidative stress Thus, resistance to reactive oxygen species (ROS) is likely one, though not the only, important factor in the killing of by neutrophils. Hst 5 has broad and potent candidacidal activity, enabling it to combat MDR strains effectively.

摘要

是一种新鉴定的物种,可引起侵袭性念珠菌血症和念珠菌病。它具有广泛的多药耐药性(MDR),这在其他致病物种中未观察到。组蛋白 5(Hst 5)是一种研究充分的唾液阳离子肽,对具有显著的抗真菌活性,并且是治疗多药耐药真菌的有吸引力的候选物,因为抗菌肽诱导的耐药性最小。我们研究了 Hst 5 和中性粒细胞对的易感性,这是宿主中两种一线先天防御。大多数临床分离株,包括氟康唑耐药株,对 Hst 5 高度敏感:使用 7.5 μM Hst 5 可杀死 55%至 90%的细胞。Hst 5 被转运到细胞溶胶和中;这种转运对于 Hst 5 杀死是必需的。氟康唑耐药性与 Hst 5 杀伤之间的反比关系表明,Hst 5 的细胞靶标与氟康唑不同。与相比,对氧化应激的耐受性更高,并且在中性粒细胞内的存活率更高,这与对氧化应激的抗性相关。因此,对活性氧(ROS)的耐药性可能是中性粒细胞杀伤的一个重要因素(尽管不是唯一因素)。Hst 5 具有广泛而有效的杀真菌活性,能够有效对抗 MDR 菌株。

相似文献

1
Fluconazole-Resistant Candida auris Is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses.氟康唑耐药的耳念珠菌易被唾液组蛋白 5 杀伤,且易被固有宿主防御机制杀灭。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01872-17. Print 2018 Feb.
2
Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species.θ-防御素对多种耐药性念珠菌属种的抗真菌效力和作用机制。
Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.00111-18. Print 2018 Jun.
3
Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates of and .孔形成肽 C14R 对 和 的临床分离株表现出强大的抗真菌活性。
Front Cell Infect Microbiol. 2024 Mar 27;14:1389020. doi: 10.3389/fcimb.2024.1389020. eCollection 2024.
4
Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans.唾液组蛋白的杀念珠菌活性。白色念珠菌上组蛋白5结合蛋白的鉴定。
J Biol Chem. 1998 Aug 7;273(32):20438-47. doi: 10.1074/jbc.273.32.20438.
5
Histatin-5 induces the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisae.组蛋白-5 诱导酿酒酵母中 Pdr5p 介导的氟康唑耐药性的逆转。
J Mycol Med. 2018 Mar;28(1):137-142. doi: 10.1016/j.mycmed.2017.11.002. Epub 2017 Dec 6.
6
Histatin 5 resistance of Candida glabrata can be reversed by insertion of Candida albicans polyamine transporter-encoding genes DUR3 and DUR31.光滑念珠菌多胺转运蛋白编码基因 DUR3 和 DUR31 的插入可逆转近平滑念珠菌的组蛋白 5 耐药性。
PLoS One. 2013 Apr 22;8(4):e61480. doi: 10.1371/journal.pone.0061480. Print 2013.
7
Sphingolipidomics of drug resistant Candida auris clinical isolates reveal distinct sphingolipid species signatures.耐药性耳念珠菌临床分离株的神经鞘脂组学研究揭示了独特的神经鞘脂种类特征。
Biochim Biophys Acta Mol Cell Biol Lipids. 2021 Jan;1866(1):158815. doi: 10.1016/j.bbalip.2020.158815. Epub 2020 Sep 15.
8
The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.新兴病原体耳念珠菌:生长表型、毒力因子、抗真菌药物活性以及新型葡聚糖合成抑制剂SCY-078对生长形态和生物膜形成的影响
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02396-16. Print 2017 May.
9
Iron binding modulates candidacidal properties of salivary histatin 5.铁结合调节唾液组蛋白5的杀念珠菌特性。
J Dent Res. 2015 Jan;94(1):201-8. doi: 10.1177/0022034514556709. Epub 2014 Nov 3.
10
Human salivary histatin 5 fungicidal action does not induce programmed cell death pathways in Candida albicans.人唾液组蛋白5的杀真菌作用不会诱导白色念珠菌的程序性细胞死亡途径。
Antimicrob Agents Chemother. 2004 Jan;48(1):110-5. doi: 10.1128/AAC.48.1.110-115.2004.

引用本文的文献

1
Innovative antifungal strategies to combat drug-resistant : recent advances and clinical implications.对抗耐药性的创新抗真菌策略:最新进展与临床意义
Front Cell Infect Microbiol. 2025 Jul 31;15:1641373. doi: 10.3389/fcimb.2025.1641373. eCollection 2025.
2
Monoclonal antibodies targeting Candida disrupt biofilms and inhibit growth across global clinical isolates.靶向念珠菌的单克隆抗体可破坏生物膜并抑制全球临床分离株的生长。
iScience. 2025 Apr 16;28(5):112459. doi: 10.1016/j.isci.2025.112459. eCollection 2025 May 16.
3
Reducing Functional Domain of Histatin 5 Improves Antifungal Activity and Prevents Proteolytic Degradation.组蛋白5功能域的缩减可提高抗真菌活性并防止蛋白水解降解。
Microorganisms. 2025 May 8;13(5):1091. doi: 10.3390/microorganisms13051091.
4
Infections: The Role of Saliva in Oral Health-A Narrative Review.感染:唾液在口腔健康中的作用——一篇叙述性综述
Microorganisms. 2025 Mar 23;13(4):717. doi: 10.3390/microorganisms13040717.
5
The multidrug-resistant complex and phylogenetic related species: Insights into antifungal resistance mechanisms.多重耐药复合体及系统发育相关物种:对抗真菌耐药机制的见解
Curr Res Microb Sci. 2025 Jan 28;8:100354. doi: 10.1016/j.crmicr.2025.100354. eCollection 2025.
6
Design of Natterins-based peptides improves antimicrobial and antiviral activities.基于纳特菌素的肽的设计提高了抗菌和抗病毒活性。
Biotechnol Rep (Amst). 2024 Nov 28;45:e00867. doi: 10.1016/j.btre.2024.e00867. eCollection 2025 Mar.
7
Insight into Virulence and Mechanisms of Amphotericin B Resistance in the Complex.深入了解该复合体中两性霉素B耐药性的毒力及机制。
J Fungi (Basel). 2024 Aug 28;10(9):615. doi: 10.3390/jof10090615.
8
Comparative fitness trade-offs associated with azole resistance in clinical isolates.临床分离株中与唑类抗性相关的相对适合度权衡
Heliyon. 2024 Jun 4;10(12):e32386. doi: 10.1016/j.heliyon.2024.e32386. eCollection 2024 Jun 30.
9
Innate immune response to Candida auris.对耳念珠菌的固有免疫反应。
Curr Opin Microbiol. 2024 Aug;80:102510. doi: 10.1016/j.mib.2024.102510. Epub 2024 Jul 3.
10
Current Perspectives of Antifungal Therapy: A Special Focus on .抗真菌治疗的当前观点:特别关注于…… (原文不完整,翻译到这里截止)
J Fungi (Basel). 2024 Jun 6;10(6):408. doi: 10.3390/jof10060408.

本文引用的文献

1
for the clinical microbiology laboratory: Not your grandfather's species.献给临床微生物学实验室:并非你祖父时代的物种。
Clin Microbiol Newsl. 2017 Jul 1;39(13):99-103. doi: 10.1016/j.clinmicnews.2017.06.003.
2
Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally.耳念珠菌:全球医院获得性多重耐药真菌感染的一个迅速出现的病因。
PLoS Pathog. 2017 May 18;13(5):e1006290. doi: 10.1371/journal.ppat.1006290. eCollection 2017 May.
3
Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities - United States, June 2016-May 2017.实地记录:2016年6月至2017年5月美国医疗机构中耳念珠菌的持续传播
MMWR Morb Mortal Wkly Rep. 2017 May 19;66(19):514-515. doi: 10.15585/mmwr.mm6619a7.
4
Human Salivary Protein Histatin 5 Has Potent Bactericidal Activity against ESKAPE Pathogens.人唾液蛋白组蛋白5对ESKAPE病原体具有强大的杀菌活性。
Front Cell Infect Microbiol. 2017 Feb 15;7:41. doi: 10.3389/fcimb.2017.00041. eCollection 2017.
5
The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.新兴病原体耳念珠菌:生长表型、毒力因子、抗真菌药物活性以及新型葡聚糖合成抑制剂SCY-078对生长形态和生物膜形成的影响
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02396-16. Print 2017 May.
6
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.高毒力、多重耐药耳念珠菌的生物膜形成能力
Emerg Infect Dis. 2017 Feb;23(2):328-331. doi: 10.3201/eid2302.161320.
7
Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel.多重耐药的哈氏假丝酵母菌和耳念珠菌,以色列特拉维夫
Emerg Infect Dis. 2017 Feb;23(1):195-203. doi: 10.3201/eid2302.161486.
8
Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus-United States, May 2013-August 2016.2013年5月至2016年8月美国对全球新出现的侵袭性、多重耐药真菌——耳念珠菌的前七例报告病例的调查。
Am J Transplant. 2017 Jan;17(1):296-299. doi: 10.1111/ajt.14121.
9
Emergence of Candida auris: An International Call to Arms.耳念珠菌的出现:国际的战斗号召。
Clin Infect Dis. 2017 Jan 15;64(2):141-143. doi: 10.1093/cid/ciw696. Epub 2016 Oct 20.
10
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.全基因组测序和流行病学分析证实三大洲同时出现多重耐药性耳念珠菌
Clin Infect Dis. 2017 Jan 15;64(2):134-140. doi: 10.1093/cid/ciw691. Epub 2016 Oct 20.